Biora Therapeutics Stock (NASDAQ:BIOR)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$0.60

52W Range

$0.26 - $19.90

50D Avg

$2.54

200D Avg

$5.95

Market Cap

$2.67M

Avg Vol (3M)

$131.97K

Beta

1.28

Div Yield

-

BIOR Company Profile


Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ingestible capsule for needle-free delivery of biotherapeutics directly into the intestinal mucosa for enhanced systemic uptake. It is also developing diagnostics devices to help characterize the GI tract and diagnose GI diseases, such as small intestine bacterial overgrowth through the development of various technologies to diagnose at the site of the disease. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

58

IPO Date

Jun 19, 2020

Website

BIOR Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 21Dec 20
Commercial Third Party Payors$42.10M$64.43M
Patient Laboratory Distribution Partners$4.42M$7.15M
Government Health Benefit Programs$14.09M$2.73M

Fiscal year ends in Dec 23 | Currency in USD

BIOR Financial Summary


Dec 23Dec 22Dec 21
Revenue$4.00K$305.00K$1.25M
Operating Income$-67.14M$-61.78M$-117.84M
Net Income$-124.11M$-48.83M$-178.52M
EBITDA$-66.59M$-59.16M$-63.68M
Basic EPS$-7.87$-6.40$-46.42
Diluted EPS$-7.87$-6.40$-46.42

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 24Aug 12, 24 | 7:54 PM
Q1 24May 15, 24 | 6:29 PM
Q4 23Mar 26, 24 | 7:54 PM

Peer Comparison


TickerCompany
ZVSAZyVersa Therapeutics, Inc.
ZURAZura Bio Limited
ELEVElevation Oncology, Inc.
OCEAOcean Biomedical, Inc.
HEPAHepion Pharmaceuticals, Inc.
ENVBEnveric Biosciences, Inc.